Skip to content

Impact of real-world based combined Chinese and Western medicine treatment on blood pressure attainment in patients with essential hypertension

Impact of real-world based combined Chinese and Western medicine treatment on blood pressure attainment in patients with essential hypertension

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074768
Enrollment
Unknown
Registered
2023-08-16
Start date
2023-08-16
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential hypertension

Interventions

Western medicine treatment group:NA
Integrative Chinese and Western Medicine Treatment Group:NA

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Western medical diagnosis meets the diagnostic criteria for essential hypertension; ? Those who did not achieve ideal blood pressure control, as evidenced by office blood pressure systolic blood pressure (SBP) =140 mmHg and/or diastolic blood pressure (DBP) =90 mmHg on 3 measurements not taken on the same day; ? Those taking Western antihypertensive drug therapy before the start of the study or on day 1 after the start of the study. ? Age between 18 and 80 years old, gender is not limited; ? Patients voluntarily participated in the trial and signed an informed consent form, with a high degree of obedience and co-operative attitude.

Exclusion criteria

Exclusion criteria: 1. Secondary hypertension, hypertension during pregnancy. 2. Patients with cardiovascular diseases such as acute coronary syndrome, severe heart failure (NYHA class III or above), severe arrhythmia, heart valve disease, cardiomyopathy, etc. 3. Patients in the acute stage of cerebrovascular diseases such as cerebral haemorrhage and cerebral infarction. 4. Those who take sedative and sleeping drugs. 5. Shift workers. 6. Those suffering from severe liver or kidney dysfunction, hematopoietic system diseases, malignant tumours or those with an expected survival time of less than one year. 7. Those with serious psychological disorder, mental retardation or speech disorder. 8. Those who are pregnant, breastfeeding or planning to become pregnant.

Design outcomes

Primary

MeasureTime frame
Blood pressure compliance rate;

Secondary

MeasureTime frame
Changes in blood pressure in the clinic;TCM Syndrome Points;Hypertension symptom score;quality of life indicators;

Countries

China

Contacts

Public ContactYao Kuiwu

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

yaokuiwu@126.com+86 186 1036 6611

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026